Kala Bio Inc’s filing revealed that its Former 10% owner BAKER BROS. ADVISORS LP unloaded Company’s shares for reported $0.71 million on Oct 01 ’25. In the deal valued at $1.38 per share,513,607 shares were sold. As a result of this transaction, BAKER BROS. ADVISORS LP now holds 46,480 shares worth roughly $70649.6.
Then, BAKER BROS. ADVISORS LP sold 216,801 shares, generating $345,993 in total proceeds. Upon selling the shares at $1.60, the Former 10% owner now owns 97,120 shares.
Before that, Kharabi Darius sold 4,511 shares. Kala Bio Inc shares valued at $18,089 were divested by the CHIEF BUSINESS OFFICER at a price of $4.01 per share. As a result of the transaction, Kharabi Darius now holds 62,566 shares, worth roughly $95100.32.
Mizuho downgraded its Kala Bio Inc [KALA] rating to a Neutral from a an Outperform in a research note published recently. A number of analysts have revised their coverage, including Ladenburg Thalmann’s analysts, who decreased its forecast for the stock in late September from “a Buy” to “a Neutral”. H.C. Wainwright also remained covering KALA and has decreased its forecast on September 29, 2025 with a “Neutral” recommendation from previously “Buy” rating. Mizuho started covering the stock on September 08, 2025. It rated KALA as “an Outperform”.
Price Performance Review of KALA
On Monday, Kala Bio Inc [NASDAQ:KALA] saw its stock fall -1.30% to $1.52. Over the last five days, the stock has lost -25.67%. Kala Bio Inc shares have fallen nearly -71.80% since the year began. Nevertheless, the stocks have fallen -78.10% over the past one year. While a 52-week high of $20.60 was reached on 09/17/25, a 52-week low of $1.10 was recorded on 09/29/25.
Levels Of Support And Resistance For KALA Stock
The 24-hour chart illustrates a support level at 1.4833, which if violated will result in even more drops to 1.4467. On the upside, there is a resistance level at 1.5833. A further resistance level may holdings at 1.6467.
How much short interest is there in Kala Bio Inc?
A steep rise in short interest was recorded in Kala Bio Inc stocks on 2025-09-15, growing by 0.25 million shares to a total of 0.65 million shares. Yahoo Finance data shows the prior-month short interest on 2025-08-15 was 0.4 million shares. There was a rise of 38.75%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on July 11, 2025 when Ladenburg Thalmann began covering the stock and recommended ‘”a Buy”‘ rating along with a $12 price target.
